News

Assessing Vertex Pharmaceuticals: Insights From 9 Financial Analysts
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $481.56, ...
Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q2 Sales Beat Estimates But Stock Drops 13.5%
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 12.1% year on year to $2.96 billion. The company expects the full ...
What To Expect From Vertex Pharmaceuticals’s (VRTX) Q2 Earnings
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting earnings this Monday after the bell. Here’s what to ...
The 3 Things That Matter for Vertex Pharmaceuticals Now
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Reuters1y
US FDA advisers to determine need for more studies of Vertex/CRISPR ...
US FDA advisers to determine need for more studies of Vertex/CRISPR gene therapy By Sriparna Roy October 27, 20238:57 AM PDTUpdated October 27, 2023 ...